ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 PROpel Phase III Trial Highlights: Olaparib & Abiraterone vs. Placebo & Abiraterone as 1L Therapy for mCRPC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Fred Saad
By
ASCO Genitourinary Cancers Symposium
FEATURING
Fred Saad
364 views
March 8, 2022
Comments 0
Login to view comments.
Click here to Login
Videos